LMF
ENZ

LMR Master Fund’s Enzo Biochem, Inc. ENZ Stock Holding History

LMR Master Fund’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-172,696
Closed -$435K – 438
2013
Q3 		$435K Sell
172,696
-27,304
-14% -$64.7K 0.08% 219
2013
Q2 		$416K Buy
+200,000
New +$441K 0.04% 310

Other funds holding ENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
PRC
Platte River Capital Denver, Colorado $108M AUM 0.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

LMR Master Fund's ENZ Position: Q4 2013 in Review

LMR Master Fund sold out of Enzo Biochem, Inc. (ENZ) in Q4 2013, closing a stake of 172,696 shares — an estimated $435K sold.

LMR Master Fund first reported a position in ENZ in Q2 2013 and held it in 2 quarters. The position peaked at $435K in Q3 2013. 50 funds tracked by Wall St. Rank hold ENZ as of Q4 2013.

  • LMR Master Fund reported no remaining Enzo Biochem, Inc. position as of Q4 2013 after selling out during the quarter.
  • LMR Master Fund sold 172,696 Enzo Biochem, Inc. shares in Q4 2013, an estimated $435K.
  • LMR Master Fund first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 2 quarters.
  • LMR Master Fund's Enzo Biochem, Inc. position peaked at $435K in Q3 2013.
  • 50 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.